# Comparative Performance of PureVision, Acuvue Oasys and O2Optix

> **NCT00640341** · PHASE4 · COMPLETED · sponsor: **Bausch & Lomb Incorporated** · enrollment: 510 (actual)

## Conditions studied

- Myopia

## Interventions

- **DEVICE:** PureVision Contact Lens
- **DEVICE:** Acuvue Oasys Contact Lens
- **DEVICE:** O2Optix Contact lens

## Key facts

- **NCT ID:** NCT00640341
- **Lead sponsor:** Bausch & Lomb Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 510 (ACTUAL)
- **Last updated:** 2011-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00640341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00640341, "Comparative Performance of PureVision, Acuvue Oasys and O2Optix". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00640341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
